找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: The Future of HIV-1 Therapeutics; Resistance Is Futile Bruce E. Torbett,David S. Goodsell,Douglas D. Rich Book 2015 This is a U.S. Governme

[復(fù)制鏈接]
查看: 34888|回復(fù): 43
樓主
發(fā)表于 2025-3-21 16:52:24 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書目名稱The Future of HIV-1 Therapeutics
副標(biāo)題Resistance Is Futile
編輯Bruce E. Torbett,David S. Goodsell,Douglas D. Rich
視頻videohttp://file.papertrans.cn/911/910160/910160.mp4
概述Highlights the identification and evaluation of antiretrovirals that may be less prone in selecting for HIV-1 resistance.Covers recent advances in the identification and function of small molecule inh
叢書名稱Current Topics in Microbiology and Immunology
圖書封面Titlebook: The Future of HIV-1 Therapeutics; Resistance Is Futile Bruce E. Torbett,David S. Goodsell,Douglas D. Rich Book 2015 This is a U.S. Governme
描述.This volume thoroughly covers HIV-1 antiretrovirals currently in clinical use, together with their advantages and limitations. HIV-1 inhibitor resistance is discussed in detail, and critical assessments as to what will be required of future antiretrovirals in order to halt viral replication, reduce viral resistance, and alter the state of viral latency are presented. Experts at the forefront of HIV-1 research provide overviews of approaches from the fields of virology, chemical biology and structural biology for obtaining small molecule inhibitors that target viral regulatory and structural components at multiple points in the viral lifecycle. The individual chapters will appeal to scientists and clinicians alike..
出版日期Book 2015
關(guān)鍵詞Fragment-based drug design; HIV Gag protein; HIV capsid; HIV integrase protein; HIV matrix; HIV nucleocap
版次1
doihttps://doi.org/10.1007/978-3-319-18518-7
isbn_softcover978-3-319-37450-5
isbn_ebook978-3-319-18518-7Series ISSN 0070-217X Series E-ISSN 2196-9965
issn_series 0070-217X
copyrightThis is a U.S. Government work and not under copyright protection in the U.S.; foreign copyright pro
The information of publication is updating

書目名稱The Future of HIV-1 Therapeutics影響因子(影響力)




書目名稱The Future of HIV-1 Therapeutics影響因子(影響力)學(xué)科排名




書目名稱The Future of HIV-1 Therapeutics網(wǎng)絡(luò)公開度




書目名稱The Future of HIV-1 Therapeutics網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱The Future of HIV-1 Therapeutics被引頻次




書目名稱The Future of HIV-1 Therapeutics被引頻次學(xué)科排名




書目名稱The Future of HIV-1 Therapeutics年度引用




書目名稱The Future of HIV-1 Therapeutics年度引用學(xué)科排名




書目名稱The Future of HIV-1 Therapeutics讀者反饋




書目名稱The Future of HIV-1 Therapeutics讀者反饋學(xué)科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 22:46:21 | 只看該作者
板凳
發(fā)表于 2025-3-22 01:33:33 | 只看該作者
Book 2015ance is discussed in detail, and critical assessments as to what will be required of future antiretrovirals in order to halt viral replication, reduce viral resistance, and alter the state of viral latency are presented. Experts at the forefront of HIV-1 research provide overviews of approaches from
地板
發(fā)表于 2025-3-22 07:04:55 | 只看該作者
5#
發(fā)表于 2025-3-22 10:44:23 | 只看該作者
6#
發(fā)表于 2025-3-22 16:21:22 | 只看該作者
7#
發(fā)表于 2025-3-22 20:41:07 | 只看該作者
978-3-319-37450-5This is a U.S. Government work and not under copyright protection in the U.S.; foreign copyright pro
8#
發(fā)表于 2025-3-22 22:58:16 | 只看該作者
The Future of HIV-1 Therapeutics978-3-319-18518-7Series ISSN 0070-217X Series E-ISSN 2196-9965
9#
發(fā)表于 2025-3-23 04:25:10 | 只看該作者
0070-217X ule inhibitors that target viral regulatory and structural components at multiple points in the viral lifecycle. The individual chapters will appeal to scientists and clinicians alike..978-3-319-37450-5978-3-319-18518-7Series ISSN 0070-217X Series E-ISSN 2196-9965
10#
發(fā)表于 2025-3-23 06:51:47 | 只看該作者
Controllable Power Semiconductors,Die weiterführende Behandlung von Patienten mit ausgepr?gten Hirnfunktionsst?rungen ist ohne . und auch vom ?rztlichen Standpunkt aus nicht zu verantworten.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-12 03:51
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
方山县| 旺苍县| 西乌| 油尖旺区| 丹寨县| 江都市| 城市| 金门县| 滦平县| 镇赉县| 临泽县| 扬州市| 华蓥市| 大英县| 安义县| 蓝田县| 元朗区| 巴南区| 上犹县| 南宫市| 固安县| 清水县| 汝阳县| 明光市| 安陆市| 宽甸| 望奎县| 安宁市| 鸡西市| 堆龙德庆县| 寿阳县| 鸡东县| 淮滨县| 务川| 新昌县| 团风县| 分宜县| 盐城市| 抚宁县| 平顺县| 平定县|